FDA allows treatment of depression with club drug's cousin

  • 📰 YahooNews
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 59%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness

The nasal spray from Johnson & Johnson is a chemical cousin of ketamine, which has been used for decades as a powerful anesthetic to prepare patients for surgery. In the 1990s, the medication was adopted as a party drug by the underground rave culture due to its ability to produce psychedelic, out-of-body experiences. More recently, some doctors have given ketamine to people with depression without formal FDA approval.

Ketamine and J&J's version work differently than those drugs, targeting a chemical called glutamate that is thought to restore brain connections that help relieve depression. Robin Prothro, 60, began taking antidepressants more than 20 years ago. But she says none of the five medications she tried relieved the depression that has stymied her personal and professional life.

"Substantially different agents are only rarely appearing from pharmaceutical companies or other laboratories," said Dr. Paul Summergrad, a psychiatrist at Tufts University."That's prompting people to investigate other compounds."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Known among Scientific Shamans

This still makes sense. It's not like he's aware of that, but the fact that doctors are trying to stop him from treating his depression.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 380. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant DepressionThe green light means ketamine–an anesthetic abused as a party drug but promoted by some doctors without FDA approval as a necessary treatment for the most severely depressed patients—has spawned the first materially new depression treatment in decades. I’m trademarking ‘Vitamin K’. Yay more opioids!! - no one ever Ohhhhhhhhhhhh! Now I get it. Johnson & Johnson,so that's how they got the approval notice that it says ketamine- derived. Instead of actually removing one's depression, after having witnessed of course, isn't it more like a giddy-headed idiot? Signed curious
Source: Forbes - 🏆 394. / 53 Read more »

For persistent depression, FDA approves a novel treatment based on ketamineFor people with intractable depression, the FDA has approved a nasal spray called esketamine, which can take effect in hours, compared to weeks or months for traditional treatments. Esketamine is a component of ketamine, which has been used as a party drug. Kinda special K MrJonCryer So we re-invented cocaine?
Source: latimes - 🏆 11. / 82 Read more »

Nasal spray drug related to ketamine approved by FDA to treat depressionThe FDA approved esketamine, an experimental nasal spray that delivers the active ingredients of the “club drug” ketamine, as a new treatment for severe depression. DrCharles_NBC lilpump ESSKEETIT 😭😂 DrCharles_NBC If you can't beat em, join em.. DrCharles_NBC Fuck Yes!!! Finally the FDA does something cool for a change!!
Source: NBCNews - 🏆 10. / 86 Read more »

Stocks under pressure | Ex-Nissan CEO post bail | New depression treatment approvedFutures are pointing to a mostly lower open for the Wednesday session, with Wall Street stuck in a mild funk. Gts güzel resim 🔺👁️ Dems launch another witch hunt, stocks dip. Are Dems not obviously terrible for your 401K? The new green deal Democrats are bent on self destruction of US.
Source: CNBC - 🏆 12. / 72 Read more »